CN103656042B - A kind of medicine for the treatment of herpes zoster - Google Patents
A kind of medicine for the treatment of herpes zoster Download PDFInfo
- Publication number
- CN103656042B CN103656042B CN201310678666.8A CN201310678666A CN103656042B CN 103656042 B CN103656042 B CN 103656042B CN 201310678666 A CN201310678666 A CN 201310678666A CN 103656042 B CN103656042 B CN 103656042B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- medicine
- herpes zoster
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a kind of medicine for the treatment of herpes zoster, this medicine with Flos Lonicerae 22 parts, Herba Taraxaci 18 parts, Radix Bupleuri 15 parts, Radix Paeoniae Rubra 12 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 10 parts, Rhizoma Corydalis 8 parts, Rhizoma Cyperi 8 parts, Fructus Toosendan 6 parts is raw material, has good effect to the treatment of herpes zoster, and have no side effect, not easily recur after healing, effective percentage is 92%, cure rate 90%.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of medicine for the treatment of herpes zoster.
Background technology
Herpes zoster is the actute infection dermatoses caused by varicella zoster virus, can betide any one position of health, common with lower back, its main manifestations is for bunch catchmenting bubble, zonal distribution of trooping is done, often with obvious neuralgia and regional glandular enlargement along side peripheral nerve.Dermexanthesis is gone to toward having heating, weak, inappetence, the symptoms such as affected part hyperesthesia and neuralgia.TCM identification for herpes zoster many because dampness-heat in the liver and gallbladder, fire-toxin are flourishing, caused by depression and stagnation of QI.At present, the method for the treatment of herpes zoster is more both at home and abroad, as western medical treatment commonly uses vitamin B
1, B
12deng, eliminating inflammation and expelling toxin method, LIUSHEN WAN etc. are commonly used in Chinese traditional treatment.But be difficult to reach the effect making patient satisfaction in therapeutic effect.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of herpes zoster, this medicine with Flos Lonicerae, Herba Taraxaci, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Radix Paeoniae Rubra, Rhizoma Corydalis, Fructus Toosendan, Pericarpium Citri Reticulatae, Rhizoma Cyperi for raw material, good effect is had to the treatment of herpes zoster, and have no side effect, not easily recur after healing.
For achieving the above object, the present invention adopts following technical scheme:
A kind of medicine for the treatment of herpes zoster, it is characterized in that: the formula of described medicine and the weight portion of raw material are: Flos Lonicerae 20 ~ 25 parts, Herba Taraxaci 18 ~ 25 parts, Radix Bupleuri 15 ~ 25 parts, Radix Paeoniae Rubra 10 ~ 15 parts, the Rhizoma Atractylodis Macrocephalae 8 ~ 20 parts, Rhizoma Alismatis 6 ~ 12 parts, Pericarpium Citri Reticulatae 10 ~ 18 parts, Rhizoma Corydalis 6 ~ 12 parts, Rhizoma Cyperi 5 ~ 10 parts, Fructus Toosendan 3 ~ 8 parts.
The formula of described medicine and the weight portion of raw material are: Flos Lonicerae 22 parts, Herba Taraxaci 18 parts, Radix Bupleuri 15 parts, Radix Paeoniae Rubra 12 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 10 parts, Rhizoma Corydalis 8 parts, Rhizoma Cyperi 8 parts, Fructus Toosendan 6 parts.
The medicine for the treatment of herpes zoster of the present invention is suitable for the said any one dosage form of pharmaceutics, as Chinese medicine oral liquid, capsule.
Drug action mechanism of the present invention is:
Flos Lonicerae: cold in nature, sweet in the mouth, enters lung, the heart, stomach warp, has effect of heat-clearing and toxic substances removing, removing heat from bloodization silt.
Herba Taraxaci: property is put down, and sweet in the mouth, micro-hardship, enter spleen, stomach, kidney channel, has effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
Radix Bupleuri: cold nature, bitter in the mouth, pungent, return liver, gallbladder meridian, there is depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, loose effect of fire.
The Rhizoma Atractylodis Macrocephalae: warm in nature, sweet in the mouth, hardship, return spleen, stomach warp, has effect of air making-up and spleen enlivening, dampness diuretic.
Rhizoma Alismatis: cold in nature, sweet in the mouth, light, enter kidney, urinary bladder channel, have promoting diuresis to eliminate damp pathogen, expel the heat-evil treating stranguria effect.
Radix Paeoniae Rubra: cold nature, bitter in the mouth, returns Liver Channel, has clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling.
Rhizoma Corydalis: warm in nature, bitter in the mouth, pungent, return liver, the heart, stomach warp, there is promoting blood circulation to remove blood stasis, effect of promoting the circulation of QI to relieve pain.
Fructus Toosendan: cold in nature, bitter in the mouth, slightly poisonous, enter Liver Channel, there is catharsis liver-heat, effect of promoting the circulation of QI to relieve pain.
Pericarpium Citri Reticulatae: warm in nature, bitter in the mouth, pungent, return lung, spleen channel, there is regulating qi-flowing for strengthening spleen, effect of drying dampness to eliminate phlegm.
Rhizoma Cyperi: property is put down, and acrid in the mouth, micro-hardship is sweet, enters liver, tri-jiao channel, has the effect of resolving depression of regulating the flow of vital energy.
Patients with Herpes Zoster site of pathological change in breast side of body position, belongs to Liver Channel mostly.This formula with Herba Taraxaci, Flos Lonicerae, Radix Paeoniae Rubra, Radix Bupleuri for monarch drug heat-clearing and toxic substances removing, minister is with the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Pericarpium Citri Reticulatae invigorating spleen to remove dampness, assistant is with Rhizoma Corydalis, Rhizoma Cyperi dispersing the depressed liver-QI for alleviating pain, enter Liver Channel with Fructus Toosendan for making guiding drug, all medicines are harmonious and have effect of clearing away heat-damp and promoting diuresis, eliminating fire and detoxication, promoting the circulation of QI to relieve pain, can effectively alleviate affected part pain,, depression and stagnation of QI flourishing to dampness-heat in the liver and gallbladder, fire-toxin has good therapeutic effect, and not easily recur after curing, effective percentage is 92%, cure rate 90%.
Detailed description of the invention
Embodiment 1
Treat a medicine for herpes zoster, the weight portion of its formula and raw material is: Flos Lonicerae 22 parts, Herba Taraxaci 18 parts, Radix Bupleuri 15 parts, Radix Paeoniae Rubra 12 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 10 parts, Rhizoma Corydalis 8 parts, Rhizoma Cyperi 8 parts, Fructus Toosendan 6 parts.
Embodiment 2
Treat a medicine for herpes zoster, the weight portion of its formula and raw material is: Flos Lonicerae 25 parts, Herba Taraxaci 20 parts, Radix Bupleuri 23 parts, Radix Paeoniae Rubra 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 18 parts, Rhizoma Corydalis 12 parts, Rhizoma Cyperi 5 parts, Fructus Toosendan 8 parts.
Embodiment 3
Treat a medicine for herpes zoster, the weight portion of its formula and raw material is: Flos Lonicerae 20 parts, Herba Taraxaci 23 parts, Radix Bupleuri 25 parts, Radix Paeoniae Rubra 10 parts, the Rhizoma Atractylodis Macrocephalae 20 parts, Rhizoma Alismatis 12 parts, Pericarpium Citri Reticulatae 15 parts, Rhizoma Corydalis 6 parts, Rhizoma Cyperi 10 parts, Fructus Toosendan 5 parts.
Embodiment 4
Treat a medicine for herpes zoster, the weight portion of its formula and raw material is: Flos Lonicerae 21 parts, Herba Taraxaci 25 parts, Radix Bupleuri 20 parts, Radix Paeoniae Rubra 13 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Rhizoma Alismatis 8 parts, Pericarpium Citri Reticulatae 12 parts, Rhizoma Corydalis 5 parts, Rhizoma Cyperi 6 parts, Fructus Toosendan 3 parts.
model case
Case 1, defend so-and-so, man, 45 years old.Suffer from herpes zoster ten days time medical, site of pathological change prolongs and arm at right side chest, festers after herpes is broken, pain; Western medicine transfusion, acupuncture etc. are failed to respond to any medical treatment; Put on the skin to take after the drug decocting of embodiment 1 to be equipped with outside Calamine Lotion for five days, took rear pain the same day and alleviate, to take after three days rotten position incrustation, then take and be almost recovered for two days.
Case 2, Chen, man, 63 years old.Suffer from left side Acute herpes zoster time medical one week, blister is large, and area is large, part herpes ulceration, and inflammatory seep is serious, with spasmic pain; Conventional infusion is failed to respond to any medical treatment; Put on the skin to take after the drug decocting of embodiment 1 to be equipped with outside Calamine Lotion for five days, took rear pain the same day and alleviate, take rotten position incrustation after three days, remaining medicine takes rear recovery from illness again.
Case 3, journey so-and-so, female, 72 years old.Suffer from herpes zoster two weeks, site of pathological change is at left side Head And Face, and herpes is prolonged and scalp and eye, and headache is more than, and Western medicine and multiple method are failed to respond to any medical treatment; To take five days after the drug decocting of embodiment 1, then be equipped with outside Calamine Lotion and put on the skin, took rear pain the same day and alleviate, take blister shrivelled, ulcer surface incrustation successively after five days, continuously take five doses and be almost recovered.
Case 4, fourth, man, 68 years old.Suffer from right lateral thigh herpes zoster more than ten day time medical, blister is many, and blister is tiny, but herpes area is large, prolongs and crissum, lower limb are ached, twin pain; Western medicine routine treatment is invalid; To take five days after the drug decocting of embodiment 1, be equipped with outside Calamine Lotion and put on the skin, take rear same day pain perception and alleviate, take blister after three days shrivelled successively, continuously take five doses and be almost recovered.
The foregoing is only preferred embodiment of the present invention, all equalizations done according to the present patent application the scope of the claims change and modify, and all should belong to covering scope of the present invention.
Claims (2)
1. treat the medicine of herpes zoster for one kind, it is characterized in that: the formula of described medicine and the weight portion of raw material are: Flos Lonicerae 20 ~ 25 parts, Herba Taraxaci 18 ~ 25 parts, Radix Bupleuri 15 ~ 25 parts, Radix Paeoniae Rubra 10 ~ 15 parts, the Rhizoma Atractylodis Macrocephalae 8 ~ 20 parts, Rhizoma Alismatis 6 ~ 12 parts, Pericarpium Citri Reticulatae 10 ~ 18 parts, Rhizoma Corydalis 6 ~ 12 parts, Rhizoma Cyperi 5 ~ 10 parts, Fructus Toosendan 3 ~ 8 parts.
2. the medicine for the treatment of herpes zoster according to claim 1, is characterized in that: the formula of described medicine and the weight portion of raw material are: Flos Lonicerae 22 parts, Herba Taraxaci 18 parts, Radix Bupleuri 15 parts, Radix Paeoniae Rubra 12 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 10 parts, Rhizoma Corydalis 8 parts, Rhizoma Cyperi 8 parts, Fructus Toosendan 6 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310678666.8A CN103656042B (en) | 2013-12-14 | 2013-12-14 | A kind of medicine for the treatment of herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310678666.8A CN103656042B (en) | 2013-12-14 | 2013-12-14 | A kind of medicine for the treatment of herpes zoster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103656042A CN103656042A (en) | 2014-03-26 |
| CN103656042B true CN103656042B (en) | 2015-11-18 |
Family
ID=50295601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310678666.8A Active CN103656042B (en) | 2013-12-14 | 2013-12-14 | A kind of medicine for the treatment of herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103656042B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267539A (en) * | 2015-11-18 | 2016-01-27 | 杜英凤 | Traditional Chinese medicine composition for treating herpes zoster |
| CN105902718A (en) * | 2016-06-17 | 2016-08-31 | 杜威 | External liniment for treating herpes zoster |
| CN105902715A (en) * | 2016-07-13 | 2016-08-31 | 王云龙 | Externally applied traditional Chinese medicine for treating herpes zoster |
| CN107693573A (en) * | 2017-10-17 | 2018-02-16 | 珠海横琴新区德群中医药科学研究院有限公司 | It is a kind of to be used to treat Chinese medicine composition of herpes zoster and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721564A (en) * | 2008-10-30 | 2010-06-09 | 宋修芳 | Traditional Chinese medicine for treating shingles |
-
2013
- 2013-12-14 CN CN201310678666.8A patent/CN103656042B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721564A (en) * | 2008-10-30 | 2010-06-09 | 宋修芳 | Traditional Chinese medicine for treating shingles |
Non-Patent Citations (1)
| Title |
|---|
| 辩证分型论治带状疱疹46例;张青等;《陕西中医》;20100430;第31卷(第4期);第447页右栏第1段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103656042A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103656042B (en) | A kind of medicine for the treatment of herpes zoster | |
| CN103182019B (en) | Traditional Chinese medicine composition for treating ROU (recurrent oral ulcer) | |
| CN102397415A (en) | Medicine for toothache caused by deficiency fire | |
| CN103800827A (en) | Traditional Chinese medicine for treating liver cancer | |
| CN103285334B (en) | Prescription for treatment of depressive neurosis | |
| CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102335265A (en) | Chinese medicament for treating psoriasis | |
| CN104000893A (en) | Traditional Chinese medicine oral liquid for treating rhinitis | |
| CN103285263A (en) | Medicine for treating psoriasis vulgaris | |
| CN103623157A (en) | Medicine for treating facial paralysis | |
| CN103006997B (en) | Medicine for treating post-craniotomy headache | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103610831B (en) | A kind of Chinese medicine for the treatment of neck and shoulder pain | |
| CN104689144A (en) | Drug for treating rheumatoid arthritis | |
| CN103110811B (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN101549136A (en) | Medicine for treating rheumatoid arthritis | |
| Zhuang et al. | Thoughts on the treatment of cancer pain under the guidance of traditional Chinese medicine | |
| CN105687917A (en) | Oral solution for treating arthritis | |
| CN103800619A (en) | Traditional Chinese medicine for treating rhinocarcinoma | |
| CN105287724A (en) | Medicine for treating facioplegia | |
| CN105031180A (en) | Traditional Chinese medicine preparation for treating fever and preparation method thereof | |
| CN104873712A (en) | Drug for treating addisonian syndrome | |
| CN103316221A (en) | Traditional Chinese medicine composition for treating gastrohelcosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |